NYSE:DOCS, a growth stock which is not overvalued.

Here's DOXIMITY INC-CLASS A (NYSE:DOCS) for you, a growth stock our stock screener believes is undervalued. NYSE:DOCS is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced. Let's break it down further.

Evaluating Growth: NYSE:DOCS

ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NYSE:DOCS has earned a 8 for growth:

• DOCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.62%, which is quite impressive.
• Measured over the past years, DOCS shows a very strong growth in Earnings Per Share. The EPS has been growing by 106.72% on average per year.
• Looking at the last year, DOCS shows a quite strong growth in Revenue. The Revenue has grown by 16.57% in the last year.
• Measured over the past years, DOCS shows a very strong growth in Revenue. The Revenue has been growing by 53.27% on average per year.
• DOCS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.19% yearly.
• DOCS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.62% yearly.

A Closer Look at Valuation for NYSE:DOCS

ChartMill assigns a Valuation Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing different valuation elements, such as price to earnings and free cash flow, both in absolute terms and relative to the market and industry. In the case of NYSE:DOCS, the assigned 6 reflects its valuation:

• Based on the Price/Earnings ratio, DOCS is valued cheaply inside the industry as 92.50% of the companies are valued more expensively.
• 87.50% of the companies in the same industry are more expensive than DOCS, based on the Price/Forward Earnings ratio.
• Based on the Enterprise Value to EBITDA ratio, DOCS is valued cheaply inside the industry as 85.00% of the companies are valued more expensively.
• DOCS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DOCS is cheaper than 82.50% of the companies in the same industry.
• The excellent profitability rating of DOCS may justify a higher PE ratio.
• A more expensive valuation may be justified as DOCS's earnings are expected to grow with 14.05% in the coming years.

Health Assessment of NYSE:DOCS

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NYSE:DOCS scores a 9 out of 10:

• An Altman-Z score of 25.03 indicates that DOCS is not in any danger for bankruptcy at the moment.
• DOCS has a Altman-Z score of 25.03. This is amongst the best in the industry. DOCS outperforms 95.00% of its industry peers.
• There is no outstanding debt for DOCS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
• DOCS has a Current Ratio of 8.03. This indicates that DOCS is financially healthy and has no problem in meeting its short term obligations.
• DOCS's Current ratio of 8.03 is amongst the best of the industry. DOCS outperforms 92.50% of its industry peers.
• DOCS has a Quick Ratio of 8.03. This indicates that DOCS is financially healthy and has no problem in meeting its short term obligations.
• DOCS has a better Quick ratio (8.03) than 92.50% of its industry peers.

Analyzing Profitability Metrics

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NYSE:DOCS scores a 9 out of 10:

• The Return On Assets of DOCS (13.76%) is better than 100.00% of its industry peers.
• Looking at the Return On Equity, with a value of 15.92%, DOCS belongs to the top of the industry, outperforming 97.50% of the companies in the same industry.
• With an excellent Return On Invested Capital value of 15.40%, DOCS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
• DOCS had an Average Return On Invested Capital over the past 3 years of 17.25%. This is significantly above the industry average of 4.28%.
• DOCS has a Profit Margin of 29.39%. This is amongst the best in the industry. DOCS outperforms 100.00% of its industry peers.
• In the last couple of years the Profit Margin of DOCS has grown nicely.
• With an excellent Operating Margin value of 34.75%, DOCS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
• DOCS's Operating Margin has improved in the last couple of years.
• The Gross Margin of DOCS (88.94%) is better than 97.50% of its industry peers.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Our latest full fundamental report of DOCS contains the most current fundamental analsysis.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.